Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00636441 | Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer | terminated | Phase 2 | 56 | Duke UniversityOTHER | 1 | Dec 11, 2015 | clinicaltrials |
| NCT02004496 | Randomized Controlled Single-blind Trial to Evaluate the Mobile Tracking of Symptoms in Ambulatory Breast Cancer Patients(PatAPP1) | terminated | N/A | 139 | University of ZurichOTHER | 1 | Dec 10, 2015 |
| NCT00216047 | PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 7 | Hoosier Cancer Research NetworkOTHER | 1 | Dec 9, 2015 | clinicaltrials |
| NCT00235235 | A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer | terminated | — | 80 | Hoosier Cancer Research NetworkOTHER | 2 | Dec 9, 2015 | clinicaltrials |
| NCT01391039 | Diagnostic Study of Early Breast Cancer Using Ultrasound | terminated | N/A | 12 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 30, 2015 | clinicaltrials |
| NCT01954706 | Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients(BCS2) | terminated | N/A | 5 | Baltimore VA Medical CenterFED | 1 | Nov 26, 2015 | clinicaltrials |
| NCT00777335 | Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 4 | Translational Research in OncologyOTHER | 1 | Nov 24, 2015 | clinicaltrials |
| NCT00148720 | Capecitabine in Women With Operable Breast Cancer | terminated | Phase 2 | 80 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT00891969 | Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions | terminated | — | 77 | Rutgers, The State University of New JerseyOTHER | 1 | Nov 9, 2015 | clinicaltrials |
| NCT00780000 | Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer | terminated | Phase 2 | 4 | Bristol-Myers SquibbINDUSTRY | 0 | Nov 4, 2015 | clinicaltrials |
| NCT01056757 | Treatment With Ribavirin for Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 4 | Jewish General HospitalOTHER | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00372996 | Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer | terminated | Phase 2 | 219 | PfizerINDUSTRY | 9 | Oct 28, 2015 | clinicaltrials |
| NCT02073045 | Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery | terminated | N/A | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 23, 2015 | clinicaltrials |
| NCT01809171 | Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients | terminated | Phase 2 / Phase 3 | 15 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Oct 21, 2015 | clinicaltrials |
| NCT02042456 | Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts | terminated | — | 124 | GE HealthcareINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | terminated | Phase 1 / Phase 2 | 79 | Otsuka Novel Products GmbHINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00356681 | A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer | terminated | Phase 2 | 282 | AmgenINDUSTRY | 0 | Oct 15, 2015 | clinicaltrials |
| NCT00437073 | Brain Metastases In ErbB2-Positive Breast Cancer | terminated | Phase 2 | 22 | GlaxoSmithKlineINDUSTRY | 11 | Oct 15, 2015 | clinicaltrials |
| NCT01985841 | Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer | terminated | Phase 2 | 34 | Hellenic Oncology Research GroupOTHER | 1 | Oct 8, 2015 | clinicaltrials |
| NCT01047774 | The Effect of Soy Protein on Post- Breast Cancer Surgery Pain | terminated | Phase 2 | 6 | Dr. Yoram ShirOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT01120171 | Myocet Plus Endoxan for Older Patients With Breast Cancer | terminated | Phase 2 | 64 | Hellenic Oncology Research GroupOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00909662 | Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers | terminated | — | 18 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 2, 2015 | clinicaltrials |
| NCT01837563 | Monitoring of Neoadjuvant Therapy in Locally-Advanced Breast Cancer | terminated | — | 36 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00754702 | Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer | terminated | Phase 2 | 16 | University Hospital of CreteOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT00377780 | Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer(MYOHERTAX) | terminated | Phase 2 | 60 | Laurence J.C. van WarmerdamOTHER | 1 | Sep 23, 2015 | clinicaltrials |
| NCT01238133 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer | terminated | Phase 1 | 14 | National Cancer Institute (NCI)NIH | 1 | Sep 4, 2015 | clinicaltrials |
| NCT01281163 | Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer | terminated | Phase 1 | 4 | National Cancer Institute (NCI)NIH | 1 | Aug 27, 2015 | clinicaltrials |
| NCT01161368 | A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients | terminated | Phase 2 | 9 | Central European Cooperative Oncology GroupOTHER | 2 | Aug 13, 2015 | clinicaltrials |
| NCT01548534 | A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer(DHALYA) | terminated | Phase 3 | 65 | University Hospital, ToursOTHER | 1 | Jul 29, 2015 | clinicaltrials |
| NCT01012440 | Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer | terminated | N/A | 5 | University of ChicagoOTHER | 1 | Jul 27, 2015 | clinicaltrials |
| NCT00779285 | Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED) | terminated | Phase 4 | 1 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jul 14, 2015 | clinicaltrials |
| NCT00209001 | Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer | terminated | N/A | 7 | Emory UniversityOTHER | 1 | Jul 13, 2015 | clinicaltrials |
| NCT00857714 | Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast | terminated | N/A | 1 | Indiana UniversityOTHER | 1 | Jul 8, 2015 | clinicaltrials |
| NCT01067989 | Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer | terminated | Phase 2 | 22 | HaEmek Medical Center, IsraelOTHER | 1 | Jul 8, 2015 | clinicaltrials |
| NCT01403168 | Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in Oncology(OSTEOPATHIE) | terminated | N/A | 28 | Centre Leon BerardOTHER | 1 | Jun 29, 2015 | clinicaltrials |
| NCT01334099 | Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients | terminated | Phase 1 | 6 | University Health Network, TorontoOTHER | 1 | Jun 22, 2015 | clinicaltrials |
| NCT01375023 | Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer | terminated | Phase 2 | 3 | European Institute of OncologyOTHER | 1 | Jun 22, 2015 | clinicaltrials |
| NCT00581113 | Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases | terminated | Phase 3 | 8 | Virginia Commonwealth UniversityOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT00694200 | Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer | terminated | Phase 2 | 13 | Hellenic Oncology Research GroupOTHER | 1 | May 29, 2015 | clinicaltrials |
| NCT01149356 | RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer | terminated | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | May 25, 2015 | clinicaltrials |
| NCT01701466 | Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis | terminated | Phase 2 | 14 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01262274 | Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer(Neo-ACET BC) | terminated | Phase 2 | 57 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT01750164 | Patient Derived Breast Cancer Xenografts | terminated | — | 1 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00351858 | Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer(IV REXBC 02) | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 1 | May 1, 2015 | clinicaltrials |
| NCT01569321 | Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study | terminated | N/A | 10 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01071564 | RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery | terminated | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT01368263 | Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer | terminated | Phase 2 | 8 | Washington University School of MedicineOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT00450879 | Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery | terminated | Phase 1 | 19 | National Cancer Institute (NCI)NIH | 1 | Mar 25, 2015 | clinicaltrials |
| NCT01019512 | Flexitouch Lymphedema System in Treating Stage II Lymphedema in Patients With Breast Cancer | terminated | N/A | 60 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT02008994 | Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer | terminated | Phase 2 | 5 | Sanford HealthOTHER | 1 | Mar 24, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Dec 11, 2015source: clinicaltrials